Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
종목 코드 SLP
회사 이름Simulations Plus Inc
상장일Jun 18, 1997
CEOO'Connor (Shawn M)
직원 수212
유형Ordinary Share
회계 연도 종료Jun 18
주소800 Park Offices Drive, Suite 401
도시RESEARCH TRIANGLE PARK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호27709
전화16617237723
웹사이트https://www.simulations-plus.com/
종목 코드 SLP
상장일Jun 18, 1997
CEOO'Connor (Shawn M)